Vasopressin receptor antagonists in heart failure.

Recent patents on cardiovascular drug discovery

Volumn 1, Issue 2, 2006, Pages 177-184

  Hobbs, Robert E ^a   Tang, W H Wilson ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 FLUORO 2 METHYL N (4 (5H PYRROLO(2,1 C) (1,4)BENZODIAZEPIN 10 (11H) YLCARBONYL) 3 CHLOROPHENYL)BENZAMIDE; 5-FLUORO-2-METHYL-N-(4-(5H-PYRROLO(2,1-C)-(1,4)BENZODIAZEPIN-10-(11H)-YLCARBONYL)-3-CHLOROPHENYL)BENZAMIDE; AZEPINE DERIVATIVE; BENZAMIDE DERIVATIVE; BENZAZEPINE DERIVATIVE; CONIVAPTAN; TOLVAPTAN; UNCLASSIFIED DRUG; VASOPRESSIN DERIVATIVE; VASOPRESSIN RECEPTOR;

ANIMAL; DRUG ANTAGONISM; HEART FAILURE; HUMAN; PHYSIOLOGY; REVIEW;

ANIMALS; AZEPINES; BENZAMIDES; BENZAZEPINES; HEART FAILURE; HUMANS; RECEPTORS, VASOPRESSIN; VASOPRESSINS;

EID: 39049147571     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489006777442513     Document Type: Review

References (84)